News | June 19, 2023
Alkem Laboratories launches awareness initiative "Stop Sneeze to Wheeze"
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Thiamine Hydrochloride Injection USP had estimated annual sales of USD 35 million in the U.S.
Urges Innovators to produce quality products that can be deployed at scale
Based on a subgroup analysis by PD-L1 expression from KEYNOTE-811, Merck is working with the US FDA to update the current indication for KEYTRUDA in HER2-positive gastric or GEJ adenocarcinoma
Convergent action on AMR identified as an important area of intervention
The inspection closed with zero observations
The company has now received the Establishment Inspection Report (EIR) indicating closure of the inspection
The company will submit its comprehensive response on these observations to the US FDA
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Subscribe To Our Newsletter & Stay Updated
